Jonathan Havens and Kermit Nash, partners in the law firm of Saul Ewing Arnstein & Lehr LLP, review the experience of the food and beverage industry in the pandemic, in the form of lessons learned and possible permanent changes to the supply chain.
For months, developed economies have hoarded COVID-19 vaccines and the raw materials needed to make them. Now, they’re being forced to act as an explosive outbreak in India raises the risk of new virus mutations that could threaten the wider world.
Bill Currence, president and managing partner of Cornerstone Consulting Organization, tells of the difficulties that manufacturers are experiencing in attracting workers in the midst of the pandemic, and what the employment picture will look like when it’s over.
President Biden far surpassed his original goal of administering 100 million doses of the COVID-19 vaccines within his first 100 days in office, but the initiative couldn’t have succeeded without a substantial manufacturing and logistics infrastructure backing it up.
The new focus — those who have been unable to sign up, are waiting to get a shot, or who have been reluctant or refused to be vaccinated — is a goal that requires different tactics involving smaller, more focused distribution.